Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

iSpecimen (ISPC) Net Cash Flow (2020 - 2025)

Historic Net Cash Flow for iSpecimen (ISPC) over the last 6 years, with Q3 2025 value amounting to $2.2 million.

  • iSpecimen's Net Cash Flow rose 64933.49% to $2.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.0 million, marking a year-over-year increase of 20647.04%. This contributed to the annual value of -$465258.0 for FY2024, which is 9641.14% up from last year.
  • As of Q3 2025, iSpecimen's Net Cash Flow stood at $2.2 million, which was up 64933.49% from -$192234.0 recorded in Q2 2025.
  • In the past 5 years, iSpecimen's Net Cash Flow ranged from a high of $17.9 million in Q4 2021 and a low of -$11.5 million during Q1 2023
  • Moreover, its 5-year median value for Net Cash Flow was -$399389.0 (2024), whereas its average is -$742706.0.
  • The largest annual percentage gain for iSpecimen's Net Cash Flow in the last 5 years was 696785.53% (2021), contrasted with its biggest fall of 88848.22% (2021).
  • iSpecimen's Net Cash Flow (Quarter) stood at $17.9 million in 2021, then crashed by 129.8% to -$5.3 million in 2022, then soared by 92.94% to -$377902.0 in 2023, then soared by 133.49% to $126554.0 in 2024, then soared by 1633.63% to $2.2 million in 2025.
  • Its Net Cash Flow was $2.2 million in Q3 2025, compared to -$192234.0 in Q2 2025 and -$1.1 million in Q1 2025.